Image of  Gail H Cassell

Gail H Cassell, Ph.D.

Dr. Cassell is vice president for TB Drug Development at the Infectious Disease Research Institute in Seattle, Washington, professor emeritus and former chair, Department of Microbiology, University of Alabama at Birmingham, and former vice president for scientific affairs and distinguished Lilly research scholar for infectious diseases at Eli Lilly and Company in Indianapolis, Indiana. She founded the Forum on Drug Discovery, Development and Translation, which she continues to co-chair, at the Institute of Medicine. She has a distinguished record of national service with the National Academy of Sciences, National Institutes of Health, Centers for Disease Control, and several other national and international institutions.

Affiliations:

Division of Global Health Equity, Brigham and Women's Hospital

Dr. Cassell is a leader on efforts to address multidrug-resistant tuberculosis (MDRTB). She and Barry Bloom, former dean of Harvard School of Public Health, co-lead an Institute of Medicine project on drug supply chain issues related to MDRTB. She actively advises numerous government agencies, NGOs, and foundations on the scale-up of MDRTB diagnosis and treatment in endemic areas around the world, including in Russia. Dr. Cassell is advising the GHSM Sentinel Project on pediatric drug-resistant tuberculosis, a global partnership that aims to develop and deploy evidence-based strategies to prevent child deaths from drug-resistant tuberculosis.

Isolation of a virus from Mycoplasma pulmonis.
Authors: Authors: Dybvig K, Liss A, Alderete J, Cole RM, Cassell GH.
Isr J Med Sci
View full abstract on Pubmed
Isolation of Mycoplasma pulmonis membranes and identification of surface antigens.
Authors: Authors: Horowitz SA, Garrett B, Davis JK, Cassell GH.
Infect Immun
View full abstract on Pubmed
Specific vs. nonspecific immune responses in murine respiratory mycoplasmosis.
Authors: Authors: Simecka JW, Davis JK, Cassell GH.
Isr J Med Sci
View full abstract on Pubmed
Mycoplasma pulmonis proteins common to murine mycoplasmas.
Authors: Authors: Watson HL, Cox NR, Davidson MK, Blalock DK, Davis JK, Dybvig K, Horowitz SA, Cassell GH.
Isr J Med Sci
View full abstract on Pubmed
The role of Klebsiella oxytoca in utero-ovarian infection of B6C3F1 mice.
Authors: Authors: Davis JK, Gaertner DJ, Cox NR, Lindsey JR, Cassell GH, Davidson MK, Kervin KC, Rao GN.
Lab Anim Sci
View full abstract on Pubmed
Transposition of gram-positive transposon Tn916 in Acholeplasma laidlawii and Mycoplasma pulmonis.
Authors: Authors: Dybvig K, Cassell GH.
Science
View full abstract on Pubmed
Serum antibody and cellular responses in LEW and F344 rats after immunization with Mycoplasma pulmonis antigens.
Authors: Authors: Simecka JW, Cassell GH.
Infect Immun
View full abstract on Pubmed
Measurement of antibody to Mycoplasma hominis by an enzyme-linked immunoassay and detection of class-specific antibody responses in women with postpartum fever.
Authors: Authors: Brown MB, Cassell GH, McCormack WM, Davis JK.
Am J Obstet Gynecol
View full abstract on Pubmed
Sternotomy infections with Mycoplasma hominis.
Authors: Authors: Steffenson DO, Dummer JS, Granick MS, Pasculle AW, Griffith BP, Cassell GH.
Ann Intern Med
View full abstract on Pubmed
Pathogenesis and significance of urogenital mycoplasmal infections.
Authors: Authors: Cassell GH, Davis JK, Waites KB, Rudd PT, Talkington D, Crouse D, Horowitz SA.
Adv Exp Med Biol
View full abstract on Pubmed